Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06627075

Feasibility of Surface Optical Guidance to Replace the Restraint Mask for External Radiotherapy of Head and Neck Cancer

Led by Center Eugene Marquis · Updated on 2025-02-13

40

Participants Needed

1

Research Sites

13 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating the use of surface repositioning without a restraint mask during radiotherapy sessions for patients with head and neck cancer. This study explores whether surface optical guidance alone can provide reproducible treatment positioning, potentially improving patient comfort and quality of life by eliminating the traditional mask, which can cause anxiety and discomfort. The study is sponsored by Center Eugene Marquis and focuses on patients undergoing radiotherapy for oro-rhino-laryngeal cancer. Participants will receive between 10 and a maximum of 35 radiotherapy sessions. Patients are positioned using a vacuum mattress to create a reference scan of the head, neck, and shoulders. During treatment, the surface camera system monitors patient positioning and automatically interrupts treatment if movement exceeds 3 millimeters. If necessary, a traditional thermoformed mask may be used without stopping the study. Follow-up assessments occur at 4 or 6 weeks and again at 3 months after treatment completion. Throughout the study, displacement during surface-guided radiotherapy sessions is measured to assess treatment accuracy. Healthcare professionals complete self-assessment questionnaires on session difficulty without the mask, while skin side effects are monitored weekly by radiotherapists. Patients also complete experience questionnaires at the end of treatment. The total participation duration includes treatment and follow-up assessments over approximately one year.

CONDITIONS

Brief Title

Optical Surface Guidance for External Radiotherapy of Head and Neck Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients over 18 years of age
  • Patients undergoing palliative or curative treatment for oro-rhino-laryngeal cancer
  • Patients with an indication for radiotherapy treatment, with or without complementary treatment (chemotherapy, immunotherapy), with a number of sessions between 10 and 35
  • Patients who have dated and signed an informed consent form
Not Eligible

You will not qualify if you...

  • Patients with uncontrollable movements
  • Patients under psychiatric care
  • Patients who do not understand or read French
  • Patients participating in an interventional study testing another medical intervention
  • Patients under guardianship, curatorship, safeguard of justice or deprived of liberty
  • Pregnant or breast-feeding women
  • Patients without social security coverage

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Duration of radiotherapy sessions, between 10 and 35 sessions

Participants receive surface guided radiotherapy without a face mask, positioned using a vacuum mattress and surface camera system. Treatment sessions include continuous monitoring for movement with automatic beam interruption if displacement exceeds tolerance. Participants have between 10 and 35 radiotherapy sessions.

Between 10 and 35 radiotherapy sessions

Follow-up

Duration - Up to 3 months after treatment

After the last radiotherapy session, participants are assessed by a radiotherapist to monitor skin side effects and complete patient experience questionnaires.

Visits at 4 or 6 weeks and at 3 months after treatment

Trial Site Locations

Total: 1 location

1

Centre de Lutte contre le Cancer Eugène Marquis

Rennes, Brittany Region, France, 35042

Actively Recruiting

Loading map...

Research Team

M

Marion Trochet

V

Valérie Jolaine

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here